Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Ontozry, cenobamate, Date of authorisation: 26/03/2021, Revision: 13, Status: Authorised
To register for this webinar, please click below:
Palliative Care of End-Organ Disease in Patients with Multimorbidity
The EFIM Multimorbidity Working Group is pleased to invite you to our upcoming Autumn Webinar on Palliative Care of End-Organ Disease in Patients with Multimorbidity, taking place on Thursday, 19 November at 19:00 CET.
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Date of authorisation: 27/10/2020, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 14, Status: Withdrawn
Podcast: Inside EMA
Access to documents
How to prepare and review a summary of product characteristics
ACT EU workshop on multiplicity in confirmatory clinical trials: From two-arm to platform trials , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 27 November 2026, 09:00 (CET) to 27 November 2026, 15:00 (CET)
Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI)